Klivira
Request demo

Optimizing Ophthalmology Carelon Prior Authorizations

Navigate the complexities of **ophthalmology Carelon** prior authorizations with Klivira's intelligent automation platform, designed to accelerate approvals for critical eye care.

Revenue cycle directors and prior authorization coordinators in ophthalmology face unique challenges managing utilization management requirements, particularly with major entities like Carelon (Elevance Health's UM subsidiary). The high volume of chronic anti-VEGF injections and specific surgical procedures demands a precise, efficient approach to prevent delays and denials, ensuring timely patient access to necessary treatments.

The Landscape of Ophthalmology Prior Authorization with Carelon

Carelon, as Elevance Health's utilization management entity, sets policies that directly impact ophthalmology practices. These policies often target high-cost specialty drugs and specific surgical interventions. Practices must navigate Carelon's requirements for a range of services, from chronic intravitreal injections to complex surgical procedures, to secure timely approvals for their patient cohorts.

Key Ophthalmology Procedures & Medications Requiring Carelon PA

  • Anti-VEGF intravitreal injections: Aflibercept (Eylea, Eylea HD), ranibizumab (Lucentis, biosimilars), faricimab (Vabysmo), brolucizumab (Beovu), bevacizumab (off-label).
  • Cataract surgery with premium IOL or specific lens technology.
  • Glaucoma surgical procedures: micro-invasive glaucoma surgery (MIGS), traditional trabeculectomy, tube shunts.
  • Corneal procedures: DSAEK, DMEK endothelial keratoplasty, corneal cross-linking for keratoconus.
  • Oculoplastic procedures: blepharoplasty for visual-field-affecting ptosis (medical necessity required), ectropion/entropion repair.

Critical Documentation for Ophthalmology Carelon Approvals

Successful prior authorization with Carelon hinges on submitting comprehensive, evidence-based documentation, often guided by AAO Preferred Practice Patterns. For anti-VEGF injections, this includes diagnosis confirmation via OCT and FA, visual acuity, and prior treatment response. Premium IOLs may require patient acknowledgment of out-of-pocket costs, while functional blepharoplasty necessitates visual field tests and photographs demonstrating medical necessity.

Mitigating Common Carelon Ophthalmology Denial Reasons

Practices frequently encounter denials from UM entities like Carelon due to specific policy requirements. Common ophthalmology-specific denial reasons include mandated biosimilar substitution for anti-VEGF drugs, gaps in documenting prior-treatment response for continuing cycles, challenges in distinguishing cosmetic versus medical necessity for oculoplastic procedures, and insufficient visual field documentation for glaucoma surgery or ptosis repair.

Streamlining Chronic Care & High-Volume Workflows

Ophthalmology, particularly retina practices, operates with a high volume of chronic anti-VEGF injection cycles, often requiring periodic re-authorization. The workflow is heavily dependent on OCT-based diagnostics, where findings are crucial for clinical decision-making and subsequent PA submissions. Efficiently managing these recurring authorizations and integrating diagnostic data is central to maintaining patient care continuity and revenue integrity.

Klivira's Intelligent Automation for Ophthalmology Carelon

Klivira's platform is engineered to address the specific demands of ophthalmology prior authorization, including those managed by Carelon. Our solution integrates AAO-guideline-aware anti-VEGF re-authorization workflows, automates biosimilar substitution routing based on payer policy, incorporates logic for cosmetic-vs-medical determination in oculoplastics, and streamlines the documentation of OCT findings directly into PA requests, enhancing efficiency and accuracy.

Frequently asked questions

What specific ophthalmology procedures does Carelon typically require prior authorization for?

Carelon, as Elevance Health's UM entity, commonly requires prior authorization for high-cost anti-VEGF injections (e.g., Eylea, Lucentis, Vabysmo), cataract surgery with premium IOLs, micro-invasive glaucoma surgery (MIGS), corneal cross-linking, and oculoplastic procedures like blepharoplasty when medical necessity is indicated.

How does Klivira help with the recurring prior authorizations for anti-VEGF injections managed by Carelon?

Klivira automates the periodic re-authorization process for chronic anti-VEGF injection cycles. Our platform is designed to track treatment cycles, prompt for necessary clinical documentation such as OCT findings and visual acuity, and facilitate timely submission to Carelon, minimizing administrative burden and reducing the risk of treatment delays.

What are common reasons for denial from Carelon for ophthalmology services?

Common Carelon denial reasons in ophthalmology include non-compliance with biosimilar substitution mandates for anti-VEGF drugs, insufficient documentation of prior-treatment response for ongoing therapies, lack of clear medical necessity for oculoplastic procedures, and incomplete visual field documentation for glaucoma or ptosis repair.

Does Klivira integrate with EMRs to pull ophthalmology-specific documentation for Carelon?

Yes, Klivira integrates with leading EMR systems to extract relevant ophthalmology-specific clinical documentation, such as OCT reports, visual acuity logs, and physician notes. This capability ensures that all necessary data points required by Carelon for prior authorization are accurately and efficiently compiled and submitted.

How does Klivira address the distinction between cosmetic and medically necessary oculoplastic procedures for Carelon?

Klivira incorporates logic to guide the documentation process for oculoplastic procedures, helping to differentiate between cosmetic and medically necessary interventions. Our system prompts for specific evidence, such as visual field test results and photographs demonstrating functional impairment, to support medical necessity claims to Carelon and reduce denial rates.

Related coverage

Other ophthalmology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo